Pharmacokinetics of vancomycin in adults receiving extracorporeal membrane oxygenation

Journal of the Formosan Medical Association

Volumn 115, Issue 7, 2016, Pages 560-570

  Wu, Chien Chih ^a,b   Shen, Li Jiuan ^a,b   Hsu, Li Feng ^c   Ko, Wen Je ^a   Wu, Fe Lin Lin ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c Center for Drug Evaluation   (Taiwan)

Author keywords

Critical care; Extracorporeal membrane oxygenation; Pharmacokinetics; Therapeutic drug monitoring; Vancomycin

Indexed keywords

SILICONE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; BLOOD PUMP; BLOOD SAMPLING; CENTRAL VENOUS CATHETER; CENTRIFUGAL PUMP; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; CRITICALLY ILL PATIENT; EXTRACORPOREAL OXYGENATION; FEMALE; HOLLOW FIBER; HUMAN; INFUSION; INTENSIVE CARE; KIDNEY FUNCTION; MEMBRANE OXYGENATOR; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; ROLLER PUMP; ADOLESCENT; CONTROLLED CLINICAL TRIAL; CRITICAL ILLNESS; DRUG MONITORING; MALE; MIDDLE AGED; PROSPECTIVE STUDY; STATISTICAL MODEL; TAIWAN; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CRITICAL CARE; CRITICAL ILLNESS; DRUG MONITORING; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TAIWAN; VANCOMYCIN; YOUNG ADULT;

EID: 84933054681     PISSN: 09296646     EISSN: 18760821     Source Type: Journal    
DOI: 10.1016/j.jfma.2015.05.017     Document Type: Article

References (33)

1. Bartlett R.H. Extracorporeal life support: history and new directions. ASAIO J 2005, 51:487-489.
2. Conrad S.A., Rycus P.T., Dalton H. Extracorporeal Life Support Registry Report 2004. ASAIO J 2005, 51:4-10.
3. Sun H.Y., Ko W.J., Tsai P.R., Sun C.C., Chang Y.Y., Lee C.W., et al. Infections occurring during extracorporeal membrane oxygenation use in adult patients. J Thorac Cardiovasc Surg 2010, 140. 1125-32.e2.
4. Hsueh P.R., Teng L.J., Chen W.H., Pan H.J., Chen M.L., Chang S.C., et al. Increasing prevalence of methicillin-resistant Staphylococcus aureus causing nosocomial infections at a university hospital in Taiwan from 1986 to 2001. Antimicrob Agents Chemother 2004, 48:1361-1364.
5. Burket J.S., Bartlett R.H., Vander Hyde K., Chenoweth C.E. Nosocomial infections in adult patients undergoing extracorporeal membrane oxygenation. Clin Infect Dis 1999, 28:828-833.
6. Shekar K., Fraser J.F., Smith M.T., Roberts J.A. Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation. J Crit Care 2012, 27:741.e9-741.e18.
7. Many M., Soroff H.S., Birtwell W.C., Giron F., Wise H., Deterling R.A. The physiologic role of pulsatile and nonpulsatile blood flow. II. Effects on renal function. Arch Surg 1967, 95:762-767.
8. Roy B.J., Cornish J.D., Clark R.H. Venovenous extracorporeal membrane oxygenation affects renal function. Pediatrics 1995, 95:573-578.
9. Dagan O., Klein J., Gruenwald C., Bohn D., Barker G., Koren G. Preliminary studies of the effects of extracorporeal membrane oxygenator on the disposition of common pediatric drugs. Ther Drug Monit 1993, 15:263-266.
10. Rodvold K.A., Blum R.A., Fischer J.H., Zokufa H.Z., Rotschafer J.C., Crossley K.B., et al. Vancomycin pharmacokinetics in patients with various degrees of renal function. Antimicrob Agents Chemother 1988, 32:848-852.
11. Matzke G.R., McGory R.W., Halstenson C.E., Keane W.F. Pharmacokinetics of vancomycin in patients with various degrees of renal function. Antimicrob Agents Chemother 1984, 25:433-437.
12. Krogstad D.J., Moellering R.C., Greenblatt D.J. Single-dose kinetics of intravenous vancomycin. J Clin Pharmacol 1980, 20:197-201.
13. Boeckh M., Lode H., Borner K., Hoffken G., Wagner J., Koeppe P. Pharmacokinetics and serum bactericidal activity of vancomycin alone and in combination with ceftazidime in healthy volunteers. Antimicrob Agents Chemother 1988, 32:92-95.
14. Healy D.P., Polk R.E., Garson M.L., Rock D.T., Comstock T.J. Comparison of steady-state pharmacokinetics of two dosage regimens of vancomycin in normal volunteers. Antimicrob Agents Chemother 1987, 31:393-397.
15. Amaker R.D., DiPiro J.T., Bhatia J. Pharmacokinetics of vancomycin in critically ill infants undergoing extracorporeal membrane oxygenation. Antimicrob Agents Chemother 1996, 40:1139-1142.
16. Buck M.L. Vancomycin pharmacokinetics in neonates receiving extracorporeal membrane oxygenation. Pharmacotherapy 1998, 18:1082-1086.
17. Mulla H., Pooboni S. Population pharmacokinetics of vancomycin in patients receiving extracorporeal membrane oxygenation. Br J Clin Pharmacol 2005, 60:265-275.
18. Hoie E.B., Swigart S.A., Leuschen M.P., Willett L.D., Bolam D.L., Goodrich P.D., et al. Vancomycin pharmacokinetics in infants undergoing extracorporeal membrane oxygenation. Clin Pharm 1990, 9:711-715.
19. Lan C., Tsai P.R., Chen Y.S., Ko W.J. Prognostic factors for adult patients receiving extracorporeal membrane oxygenation as mechanical circulatory support-a 14-year experience at a medical center. Artif Organs 2010, 34:e59-64.
20. Salazar D.E., Corcoran G.B. Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass. Am J Med 1988, 84:1053-1060.
21. Bauer L. Vancomycin. Applied clinical pharmacokinetics 2008, 207-298. McGraw-Hill, USA. 2 ed. L. Bauer (Ed.).
22. Gibaldi M., Perrier D. Prediction of drug concentrations on multiple dosing: using the principle of superposition. Pharmacokinetics 1982, 451-457. Marcel Dekker, New York. 2 ed. M. Gibaldi, D. Perrier (Eds.).
23. Schaad U.B., McCracken G.H., Nelson J.D. Clinical pharmacology and efficacy of vancomycin in pediatric patients. J Pediatr 1980, 96:119-126.
24. Naqvi S.H., Keenan W.J., Reichley R.M., Fortune K.P. Vancomycin pharmacokinetics in small, seriously ill infants. Am J Dis Child 1986, 140:107-110.
25. Shekar K., Roberts J.A., McDonald C.I., Fisquet S., Barnett A.G., Mullany D.V., et al. Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation. Crit Care 2012, 16:R194.
26. Sezai A., Shiono M., Orime Y., Nakata K., Hata M., Iida M., et al. Major organ function under mechanical support: comparative studies of pulsatile and nonpulsatile circulation. Artif Organs 1999, 23:280-285.
27. Wildschut E.D., Ahsman M.J., Allegaert K., Mathot R.A., Tibboel D. Determinants of drug absorption in different ECMO circuits. Intensive Care Med 2010, 36:2109-2116.
28. Barrett C.S., Jaggers J.J., Cook E.F., Graham D.A., Yarlagadda V.V., Teele S.A., et al. Pediatric ECMO outcomes: comparison of centrifugal versus roller blood pumps using propensity score matching. ASAIO J 2013, 59:145-151.
29. Rybak M., Lomaestro B., Rotschafer J.C., Moellering R., Craig W., Billeter M., et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 2009, 66:82-98.
30. Moellering R.C., Krogstad D.J., Greenblatt D.J. Vancomycin therapy in patients with impaired renal function: a nomogram for dosage. Ann Intern Med 1981, 94:343-346.
31. Wysocki M., Delatour F., Faurisson F., Rauss A., Pean Y., Misset B., et al. Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study. Antimicrob Agents Chemother 2001, 45:2460-2467.
32. Cataldo M.A., Tacconelli E., Grilli E., Pea F., Petrosillo N. Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis. J Antimicrob Chemother 2012, 67:17-24.
33. Honore P.M., Joannes-Boyau O., Boer W. The early biomarker of acute kidney injury: in search of the Holy Grail. Intensive Care Med 2007, 33:1866-1868.